The next two discretionary priority vouchers to be awarded by the FDA are reported to be heading for two MSD candidates with blockbuster potential. According to Reuters, MSD – known as Merck & Co in ...

There's a pretty good chance that, at one point or another, you've been strung along by a man who sees you as a pretty nice option, but not anywhere near a priority. It's so tempting to think that one ...

A year of significant policy change at the FDA brought momentum and scrutiny into the new year. As 2026 gets underway, biopharma companies are responding to sweeping vaccine changes while concerns ...